Insilico Medicine has dosed the first patients in a 320-person Phase III trial of rentosertib, an AI-designed drug for idiopathic pulmonary fibrosis, after earlier-stage results showed a lung-function improvement that reversed the typical decline seen on placebo.
Canada has launched Vital, a national hospital data platform founded at Toronto's St. Michael's Hospital, backed by more than $210 million and starting with near real-time data from 160 hospitals across Alberta, Ontario and Quebec.
The Department of Veterans Affairs has awarded Rise8 and Thoughtworks a contract to expand its ambient AI scribe from a 10-site pilot to all 130-plus VA medical centers nationwide, aiming to cut the paperwork burden driving clinician burnout.
Core provisions of Connecticut's Artificial Intelligence Responsibility and Transparency Act took effect October 1, 2026, adding new rules for companion chatbots, hiring algorithms, and AI-related layoff disclosures, with more deadlines still to come through 2027.
Michael Burry disclosed nearly $1.1 billion in put options against Nvidia and Palantir after warning that hyperscalers are understating GPU depreciation by a combined $176 billion, potentially inflating reported profits across the AI industry.
Apple is expected to unveil a Siri AI-powered smart home hub on October 13, 2026, that uses camera-based facial recognition — not Face ID — to personalize content for each household member, reviving questions about biometric privacy in shared living spaces.
The FTC finalized a $930,000 settlement on August 28, 2026 with Cox Media Group and two partners after finding their 'Active Listening' AI ad product never actually collected voice data and instead resold brokered email lists.
A Stanford-led study of 1,131 Character.AI users published in Nature Human Behaviour found that people with small social networks who leaned on chatbots for companionship reported lower well-being, and that sharing more with the AI was linked to feeling worse, not better.
A UNC Chapel Hill study of more than 2,300 middle schoolers found AI chatbot use jumped from 62% to 75% in four months, and students who used chatbots for emotional companionship went on to report greater loneliness and higher social anxiety.
Dartmouth's Therabot chatbot cut depression symptoms 51% in a 210-person randomized trial, and its creators are now racing to commercialize it even though the FDA has yet to clear any AI device specifically for mental health.